financetom
Business
financetom
/
Business
/
Central Garden & Pet Fiscal Q4 Swings to Non-GAAP Loss, Sales Decline; Fiscal 2025 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Central Garden & Pet Fiscal Q4 Swings to Non-GAAP Loss, Sales Decline; Fiscal 2025 Outlook Set
Nov 25, 2024 1:51 PM

04:26 PM EST, 11/25/2024 (MT Newswires) -- Central Garden & Pet ( CENT ) reported a fiscal Q4 non-GAAP loss late Monday of $0.18, swinging from a net income of $0.08 a year earlier.

Analysts surveyed by FactSet expected a loss of $0.22.

Net sales in the three months ended Sept. 28 declined to $669.5 million from $750.1 million a year earlier.

Analysts polled by FactSet expected $708 million.

The company expects fiscal 2025 EPS of at least $2.20. Analysts expect $2.44.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: TKO Group's UFC Eyes Over $1 Billion a Year From Next TV Rights Deal
Market Chatter: TKO Group's UFC Eyes Over $1 Billion a Year From Next TV Rights Deal
Jan 10, 2025
02:53 PM EST, 01/10/2025 (MT Newswires) -- TKO Group-owned (TKO) Ultimate Fighting Championship is aiming to secure more than $1 billion a year from its next media rights deal with Walt Disney's ( DIS ) ESPN, Bloomberg reported Friday. UFC and ESPN will enter an exclusive negotiation period later this month as their current deal expires at the end of...
Paramount Global Faces TV Media Pressures in 2025, UBS Says
Paramount Global Faces TV Media Pressures in 2025, UBS Says
Jan 10, 2025
02:48 PM EST, 01/10/2025 (MT Newswires) -- Paramount Global's ( PARAA ) Q4 revenue growth will stand at 6%, but a reversal of cyclical tailwinds from political advertising and the Super Bowl, along with sustained pressures in TV media will impact 2025 results, UBS said in a note Friday. We estimate TV advertising will decline high single digits year-over-year on...
Market Chatter: Lilly Close to Acquire Cancer Biotech Scorpion Therapeutics for $2.5 Billion
Market Chatter: Lilly Close to Acquire Cancer Biotech Scorpion Therapeutics for $2.5 Billion
Jan 10, 2025
02:58 PM EST, 01/10/2025 (MT Newswires) -- Eli Lilly ( LLY ) is nearing a deal to acquire privately held Scorpion Therapeutics, valuing the Boston-based company working on potential cancer treatments at around $2.5 billion, according to the Financial Times, citing sources. A deal could be announced in coming days, the sources told the newspaper. (Market Chatter news is derived...
Brazil's 'soy moratorium' faces test as Supreme Court ruling looms
Brazil's 'soy moratorium' faces test as Supreme Court ruling looms
Jan 10, 2025
SAO PAULO, Jan 10 (Reuters) - The Brazilian Supreme Court is ready to rule on a request challenging a state law that ends tax breaks for grain traders banning soy purchases from deforested areas of the Amazon rainforest after a cut-off date. The legislation was passed by the country's top soy-producing state Mato Grosso but was prevented by Justice Flavio...
Copyright 2023-2026 - www.financetom.com All Rights Reserved